| scholarly article | Q13442814 |
| P50 | author | Anja Vaskinn | Q50552206 |
| Stein Opjordsmoen Ilner | Q64169986 | ||
| Svein Friis | Q64175653 | ||
| Ole A. Andreassen | Q31229142 | ||
| Kjetil Sundet | Q47867487 | ||
| P2093 | author name string | P A Ringen | |
| C Simonsen | |||
| H Jónsdóttir | |||
| A B Birkenaes | |||
| J A Engh | |||
| P2860 | cites work | Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder | Q22241113 |
| The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder | Q48269470 | ||
| Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study. | Q50788307 | ||
| Is there an association between neurocognitive performance and medication adherence in first episode psychosis? | Q51050919 | ||
| The validity of d prime as a working memory index: results from the "Bergen n-back task". | Q51058741 | ||
| Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. | Q51850232 | ||
| Treatment nonadherence and neurocognitive impairment in bipolar disorder. | Q51868094 | ||
| Functional outcome in bipolar disorder: the role of clinical and cognitive factors. | Q51905396 | ||
| Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. | Q51927598 | ||
| Obesity as a risk factor for antipsychotic noncompliance. | Q51944586 | ||
| Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. | Q52017906 | ||
| Awareness of illness in schizophrenia and outpatient treatment adherence. | Q52891607 | ||
| A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change | Q57467323 | ||
| Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder? | Q57612624 | ||
| Measurement of Insight in Patients With Bipolar Disorder | Q57833684 | ||
| Determinants of medication compliance in schizophrenia: empirical and clinical findings | Q28254303 | ||
| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia | Q28273164 | ||
| The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
| Adherence to Medication | Q28314923 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Compliance in psychoses | Q33735941 | ||
| Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up | Q34307529 | ||
| Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group | Q34415943 | ||
| Treatment non-adherence in affective disorders. | Q34592227 | ||
| How often do patients with psychosis fail to adhere to treatment programmes? A systematic review | Q35568607 | ||
| Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes | Q35588749 | ||
| Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. | Q35942331 | ||
| Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review | Q36267419 | ||
| Identifying and improving non-adherence in bipolar disorders. | Q36286408 | ||
| Defining and assessing adherence to oral antipsychotics: a review of the literature | Q36481418 | ||
| Lack of insight in schizophrenia: impact on treatment adherence | Q36729616 | ||
| A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. | Q37304782 | ||
| Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment | Q40175775 | ||
| Clinical correlates of early medication adherence: West London first episode schizophrenia study | Q40549838 | ||
| Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization | Q40623890 | ||
| Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. | Q40634574 | ||
| What are the functional consequences of neurocognitive deficits in schizophrenia? | Q40976267 | ||
| The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description | Q41128285 | ||
| Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics | Q42748634 | ||
| Medication adherence of individuals with a first episode of psychosis | Q44133367 | ||
| Predictors of Risk of Nonadherence in Outpatients With Schizophrenia and Other Psychotic Disorders | Q44402066 | ||
| Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study | Q44709781 | ||
| Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment | Q44802846 | ||
| Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder | Q45106180 | ||
| Treatment adherence and illness insight in veterans with bipolar disorder | Q45332060 | ||
| Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders | Q46265255 | ||
| Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia | Q46630440 | ||
| Association between cannabis and psychiatric hospitalization. | Q46682447 | ||
| Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder | Q46857400 | ||
| Illicit substance use and its correlates in first episode psychosis | Q47435562 | ||
| Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia | Q47721820 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| bipolar disorder | Q131755 | ||
| P304 | page(s) | 23-33 | |
| P577 | publication date | 2012-08-17 | |
| P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
| P1476 | title | Predictors of medication adherence in patients with schizophrenia and bipolar disorder | |
| P478 | volume | 127 |
| Q38852539 | Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review |
| Q38859559 | An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments |
| Q41546064 | Antipsychotic-associated weight gain: management strategies and impact on treatment adherence |
| Q27025413 | Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates |
| Q39126835 | Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis. |
| Q35109168 | Clinical predictors of therapeutic response to antipsychotics in schizophrenia |
| Q48022142 | Community Health Workers: a Resource to Support Antipsychotic Medication Adherence |
| Q30317036 | Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review |
| Q36211694 | Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone? |
| Q38613680 | Experiences of antipsychotic use in patients with early psychosis: a two-year follow-up study |
| Q28545127 | Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia |
| Q37735808 | Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach |
| Q38430215 | Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience |
| Q45909840 | Insight change in psychosis: relationship with neurocognition, social cognition, clinical symptoms and phase of illness. |
| Q44017981 | Involuntary treatment of schizophrenia patients 2004-2010 in Denmark |
| Q64078180 | Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge |
| Q38902384 | Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review. |
| Q37684910 | Medication adherence in a comparative effectiveness trial for bipolar disorder. |
| Q42701502 | Medication nonadherence among South American patients with schizophrenia. |
| Q34465134 | Medication nonadherence and psychiatry. |
| Q35370011 | Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention |
| Q41616576 | Neuropsychological functioning, age, and medication adherence in bipolar disorder |
| Q40972932 | Peers experience of delivering a problem-solving programme to enhance antipsychotic medication adherence for individuals with schizophrenia |
| Q38125214 | Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches |
| Q55249613 | Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). |
| Q50550449 | Psychosis: clinical insight and beliefs in immigrants in their first episode. |
| Q35507000 | Strategies to improve medication adherence in patients with schizophrenia: the role of support services |
| Q36557235 | Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning |
| Q64103953 | Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review |
| Q50654393 | The bipolar maze: a roadmap through translational psychopathology. |
| Q39080703 | Treatment-adherence in bipolar disorder: A patient-centred approach |
| Q36068636 | Using the theory of planned behavior to improve treatment adherence in Mexican Americans with schizophrenia |
| Q37691609 | Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness |
Search more.